Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Miguel Turégano-Yedro, Eva Trillo-Calvo, Fernando Navarro i Ros, José David Maya-Viejo, Cruz González Villaescusa, Jose Maria Echave Sustaeta, Esperanza Doña & Bernardino Alcázar Navarrete. (2023) Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2887-2893.
Read now
Read now
Ryuhei Kondo,Jennifer Austin,Mary Akel,Vineet M. Arora,Valerie G. Press,. (2023) Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease. Journal of Asthma 60:2, pages 323-330.
Read now
Read now
Christian Gessner, Frederik Trinkmann, Sanaz Bahari Javan, Raimund Hövelmann, Valentina Bogoevska, George Georges, Elena Nudo & Carl-Peter Criée. (2022) Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 3019-3031.
Read now
Read now
David Mannino, Michael Bogart, Guillaume Germain, Shirley P Huang, Afisi S Ismaila, François Laliberté, Young Jung, Sean D MacKnight, Marjorie A Stiegler & Mei Sheng Duh. (2022) Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 491-504.
Read now
Read now
David Price, Rupert Jones, Pascal Pfister, Hui Cao, Victoria Carter, Anu Kemppinen, Björn Holzhauer, Alan Kaplan, Allan Clark, David M G Halpin, Hilary Pinnock, James D Chalmers, Job F M van Boven, Kai M Beeh, Konstantinos Kostikas, Nicolas Roche, Omar Usmani & Paul Mastoridis. (2021) Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes. Pragmatic and Observational Research 12, pages 25-35.
Read now
Read now
Mariam Fathima, Zeeta Bawa, Bernadette Mitchell, Juliet Foster, Carol Armour & Bandana Saini. (2021) COPD Management in Community Pharmacy Results in Improved Inhaler Use, Immunization Rate, COPD Action Plan Ownership, COPD Knowledge, and Reductions in Exacerbation Rates. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 519-533.
Read now
Read now
Luca Richeldi, Alessio Piraino, Francesco Macagno, Gianluigi Micarelli & Eleonora Ingrassia. (2021) The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study Protocol. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 159-166.
Read now
Read now
Omar S Usmani, Nicolas Roche, Martin Jenkins, Neda Stjepanovic, Peter Mack & Wilfried De Backer. (2021) Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 113-124.
Read now
Read now
Ileen Gilbert, Keiko Wada, Chakkarin Burudpakdee, Chirag Ghai & Laren Tan. (2020) The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control. Patient Preference and Adherence 14, pages 1463-1475.
Read now
Read now
Bo Ding, Lee Kallenbach, Lukas Slipski, Alan Wilk, Dan O’Brien & Deniz Guranlioglu. (2020) Patient Characteristics and Healthcare Resource Utilization Among Patients with COPD New to LAMA/LABA Fixed-Dose Combination Treatment in US-Based Real-World Practice. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 775-786.
Read now
Read now
Rongchang Chen, Nanshan Zhong, Hao-Yan Wang, Li Zhao, Xiaodong Mei, Zhiqiang Qin, Juan Huang, Pryseley N Assam, Andrea Maes, Shahid Siddiqui, Ubaldo J Martin & Colin Reisner. (2020) Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 43-56.
Read now
Read now
Omar S Usmani. (2019) Choosing the right inhaler for your asthma or COPD patient. Therapeutics and Clinical Risk Management 15, pages 461-472.
Read now
Read now
Hengameh M. Hosseini, Dinesh R. Pai & Daniel R. Ofak. (2019) COPD: Does Inpatient Education Impact Hospital Costs and Length of Stay?. Hospital Topics 97:4, pages 165-175.
Read now
Read now
Marija Vukoja, Ivan Kopitovic, Zorica Lazic, Branislava Milenkovic, Ivana Stankovic, Biljana Zvezdin, Aleksandra Dudvarski Ilic, Ivan Cekerevac, Miodrag Vukcevic, Vladimir Zugic & Sanja Hromis. (2019) Diagnosis and management of chronic obstructive pulmonary disease in Serbia: an expert group position statement. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1993-2002.
Read now
Read now
Michael Bogart, Richard H Stanford, François Laliberté, Guillaume Germain, Jennifer W Wu & Mei Sheng Duh. (2019) Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 343-352.
Read now
Read now
Andreas Heddini, Josefin Sundh, Magnus Ekström & Christer Janson. (2019) Effectiveness trials: critical data to help understand how respiratory medicines really work?. European Clinical Respiratory Journal 6:1.
Read now
Read now
Nicolas Roche. (2018) Stable COPD Treatment: Where are We?. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:2, pages 123-129.
Read now
Read now
Brian J Lipworth, David J Collier, Yasuhiro Gon, Nanshan Zhong, Koichi Nishi, Rongchang Chen, Samir Arora, Andrea Maes, Shahid Siddiqui, Colin Reisner & Ubaldo J Martin. (2018) Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2969-2984.
Read now
Read now
Job van der Palen, Wendy Moeskops-van Beurden, Carolyn M Dawson, Wai-Yee James, Andrew Preece, Dawn Midwinter, Neil Barnes & Raj Sharma. (2018) A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2515-2523.
Read now
Read now
David Price, Dorothy L Keininger, Boomi Viswanad, Matthias Gasser, Susann Walda & Florian S Gutzwiller. (2018) Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 695-702.
Read now
Read now
Michael DePietro, Ileen Gilbert, Lauren A. Millette & Michael Riebe. (2018) Inhalation device options for the management of chronic obstructive pulmonary disease. Postgraduate Medicine 130:1, pages 83-97.
Read now
Read now
Rupert Jones, Jessica Martin, Vicky Thomas, Derek Skinner, Jonathan Marshall, Martina Stagno d’Alcontres & David Price. (2017) The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2445-2454.
Read now
Read now
Articles from other publishers (55)
Tamas Erdelyi, Zsofia Lazar, Árpád Farkas, Peter Furi, Attila Nagy & Veronika Müller. (2023) Modeling of pulmonary deposition of agents of open and fixed dose triple combination therapies through two different low-resistance inhalers in COPD: a pilot study. Frontiers in Medicine 10.
Crossref
Crossref
Lars Hagmeyer, Silke van Koningsbruggen‐Rietschel, Sandhya Matthes, Ernst Rietschel & Winfried Randerath. (2023) From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease. The Clinical Respiratory Journal.
Crossref
Crossref
Adyam Tesfamariam Kebede, Elin Trapnes, Marianne Lea, Bjørg Abrahamsen & Liv Mathiesen. (2022) Effect of pharmacist-led inhaler technique assessment service on readmissions in hospitalized COPD patients: a randomized, controlled pilot study. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Eli Dabscheck, Johnson George, Kelcie Hermann, Christine F McDonald, Vanessa M McDonald, Renae McNamara, Mearon O’Brien, Brian Smith, Nicholas A Zwar & Ian A Yang. (2022)
COPD‐X
Australian guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2022 update
. Medical Journal of Australia 217:8, pages 415-423.
Crossref
Crossref
Patrick J. Kerr, Vincent Brennan, Elaine Mac Hale, Frank Doyle & Richard W. Costello. (2022) Improving Medication Adherence in Asthma. Seminars in Respiratory and Critical Care Medicine 43:05, pages 675-683.
Crossref
Crossref
David Mannino, Michael Bogart, Benjamin Wu, Guillaume Germain, François Laliberté, Sean D. MacKnight, Young Jung, Marjorie Stiegler & Mei Sheng Duh. (2022) Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study. Respiratory Medicine 197, pages 106807.
Crossref
Crossref
Didier Cataldo, Shane Hanon, Rudi V. Peché, Daniel J. Schuermans, Jean M. Degryse, Isabelle A. De Wulf, Karin Elinck, Mathias H. Leys, Peter L. Rummens & Eric Derom. (2022) How to Choose the Right Inhaler Using a Patient-Centric Approach?. Advances in Therapy 39:3, pages 1149-1163.
Crossref
Crossref
Fulvio Braido, Angelo G. Corsico, Davide Paleari, Alessio Piraino, Luca Cavalieri & Nicola Scichilone. (2022) Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution. Therapeutic Advances in Respiratory Disease 16, pages 175346662110660.
Crossref
Crossref
Omar S Usmani. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
754
765
.
Paschalis Steiropoulos, Petros Bakakos, Elpis Hatziagorou, Paraskevi Katsaounou, Stelios Loukides, Andriana Papaioannou, Konstantinos Porpodis, Konstantinos Samaras, Argyrios Tzouvelekis, Konstantinos Kalafatakis & Konstantinos Kostikas. (2021) The present and future of inhalation therapy for
the management of obstructive airway diseases:
Emphasis on pressurized metered-dose inhalers. Pneumon, pages 1-13.
Crossref
Crossref
Rudi Peché, Darush Attar-Zadeh, Jane Scullion & Janwillem Kocks. (2021) Matching the Inhaler to the Patient in COPD. Journal of Clinical Medicine 10:23, pages 5683.
Crossref
Crossref
Omar S. Usmani, Anthony J. Hickey, Deniz Guranlioglu, Kacey Rawson, Neda Stjepanovic, Shahid Siddiqui & Rajiv Dhand. (2021) The Impact of Inhaler Device Regimen in Patients with Asthma or COPD. The Journal of Allergy and Clinical Immunology: In Practice 9:8, pages 3033-3040.e1.
Crossref
Crossref
Gráinne d'Ancona & John Weinman. (2021) Improving adherence in chronic airways disease: are we doing it wrongly?. Breathe 17:2, pages 210022.
Crossref
Crossref
Ileen Gilbert, Aanam Aslam Mahmood, Katie Devane & Laren Tan. (2021) Association of Nonmedical Switches in Inhaled Respiratory Medications with Disruptions in Care: A Retrospective Prescription Claims Database Analysis. Pulmonary Therapy 7:1, pages 189-201.
Crossref
Crossref
Derek Nash. (2021) Poor Inhaler Adherence and Techniques – How Can We Improve It?. Current Geriatrics Reports 10:2, pages 66-71.
Crossref
Crossref
Yingmin Liang & Judith C.W. Mak. (2021) Inhaled Therapies for Asthma and Chronic Obstructive Pulmonary Disease. Current Pharmaceutical Design 27:12, pages 1469-1481.
Crossref
Crossref
Sarah E. Petite, Michael W. Hess & Herbert Wachtel. (2020) The Role of the Pharmacist in Inhaler Selection and Education in Chronic Obstructive Pulmonary Disease. Journal of Pharmacy Technology 37:2, pages 95-106.
Crossref
Crossref
Hadeer S. Harb, Nabila Ibrahim Laz, Hoda Rabea & Mohamed E. A. Abdelrahim. (2020) Real‐life assessment of chronic obstructive pulmonary disease patient performance with different inhalers. International Journal of Clinical Practice 75:4.
Crossref
Crossref
Johanna Sulku, Kristina Bröms, Marieann Högman, Christer Janson, Karin Lisspers, Andrei Malinovschi, Håkan Melhus, Björn Ställberg & Elisabet I. Nielsen. (2021) Critical inhaler technique errors in Swedish patients with COPD: a cross-sectional study analysing video-recorded demonstrations. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
E. López-Pintor, J. Grau, I. González, MC Bernal-Soriano, J.A. Quesada & B. Lumbreras. (2021) Impact of patients’ perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies. Respiratory Medicine 176, pages 106280.
Crossref
Crossref
Jens Schreiber, Tina Sonnenburg & Eva Luecke. (2020) Inhaler devices in asthma and COPD patients – a prospective cross-sectional study on inhaler preferences and error rates. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Alan Kaplan & Job F. M. van Boven. (2020) Switching Inhalers: A Practical Approach to Keep on UR RADAR. Pulmonary Therapy 6:2, pages 381-392.
Crossref
Crossref
Jørgen Vestbo, Christer Janson, Javier Nuevo & David Price. (2020) Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design. ERJ Open Research 6:4, pages 00044-2020.
Crossref
Crossref
Olivier Le Rouzic. (2020) Prise en charge de la broncho-pneumopathie chronique obstructive (BPCO) en 2020. La Presse Médicale Formation 1:2, pages 141-150.
Crossref
Crossref
Anna Claire Murphy. (2020) Inhalers: to switch or not to switch? That is the question. Thorax 75:3, pages e1-e1.
Crossref
Crossref
Mónica Helena Correia Pereira, João Miguel Bettencourt Sena Carvalho, Paula Maria Gonçalves Pinto & Maria do Carmo Oliveira Cordeiro. 2020. Noninvasive Ventilation Technologies and Healthcare for Geriatric Patients. Noninvasive Ventilation Technologies and Healthcare for Geriatric Patients
180
192
.
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta & Mario Cazzola. (2020) Triple Combination Inhalers in Chronic Obstructive Pulmonary Disease and Asthma. US Respiratory & Pulmonary Diseases 5:1, pages 18.
Crossref
Crossref
Shunya OMATSU, Mitsuru TABUSADANI, Kazumasa YAMANE, Satoshi TAKAO, Kazuki ONO, Kazuma KAWAHARA, Naoyuki YOSHIDA & Hideaki SENJU. (2020) Effects of Instruction Methods and Multidisciplinary Intervention on Inhalation Errors気管支拡張薬の吸入技術指導に関する実態調査. Rigakuryoho Kagaku 35:2, pages 193-198.
Crossref
Crossref
Haley Hoy & Louise O'Keefe. (2020) Choosing the right inhaler for the right patient: Considerations for effective management of patients with chronic obstructive pulmonary disease or asthma. Journal of the American Association of Nurse Practitioners 32:1, pages 89-99.
Crossref
Crossref
Goodarz Torkshavand, Mahnaz Khatiban & Ali Reza Soltanian. (2020) Simulation-based learning to enhance students’ knowledge and skills in educating older patients. Nurse Education in Practice 42, pages 102678.
Crossref
Crossref
Alexander J K Wilkinson, Rory Braggins, Ingeborg Steinbach & James Smith. (2019) Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England. BMJ Open 9:10, pages e028763.
Crossref
Crossref
Sinthia Bosnic‐Anticevich. (2019) Inhaler device use: Should we just forgo the detail and go for the ‘big picture’ approach?. Respirology 24:10, pages 924-925.
Crossref
Crossref
François Maltais, Gary T. Ferguson, Gregory J. Feldman, Gaëtan Deslee, Arnaud Bourdin, Harald Fjällbrant, Agnieszka Siwek-Posłuszna, Martin A. Jenkins & Ubaldo J. Martin. (2019) A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD. Advances in Therapy 36:9, pages 2434-2449.
Crossref
Crossref
Anthony D’Urzo, Kenneth R. Chapman, James F. Donohue, Peter Kardos, M. Reza Maleki-Yazdi & David Price. (2019) Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD. Pulmonary Therapy 5:1, pages 23-41.
Crossref
Crossref
Jose R Jardim & Oliver A. Nascimento. (2019) The Importance of Inhaler Adherence to Prevent COPD Exacerbations. Medical Sciences 7:4, pages 54.
Crossref
Crossref
Chin Kook Rhee, Job F.M. van Boven, Simon Wan Yau Ming, Hye Yun Park, Deog Kyeom Kim, Hae-Sim Park, Joanna Zhi Jie Ling, Kwang-Ha Yoo & David B. Price. (2019) Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation. The Journal of Allergy and Clinical Immunology: In Practice 7:3, pages 934-942.
Crossref
Crossref
Chau Ngo, Dung Phan, Giap Vu, Phu Dao, Phuong Phan, Hanh Chu, Long Nguyen, Giang Vu, Giang Ha, Tung Tran, Bach Tran, Carl Latkin, Cyrus Ho & Roger Ho. (2019) Inhaler Technique and Adherence to Inhaled Medications among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam. International Journal of Environmental Research and Public Health 16:2, pages 185.
Crossref
Crossref
Federico Lavorini, Christer Janson, Fulvio Braido, Georgios Stratelis & Anders Løkke. (2019) What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape. Therapeutic Advances in Respiratory Disease 13, pages 175346661988453.
Crossref
Crossref
Bartolome R. Celli. (2018) Pharmacological Therapy of COPD. Chest 154:6, pages 1404-1415.
Crossref
Crossref
Janwillem W. H. Kocks, Henry Chrystyn, Job van der Palen, Mike Thomas, Louisa Yates, Sarah H. Landis, Maurice T. Driessen, Mugdha Gokhale, Raj Sharma & Mathieu Molimard. (2018) Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. npj Primary Care Respiratory Medicine 28:1.
Crossref
Crossref
John D. Blakey, Bruce G. Bender, Alexandra L. Dima, John Weinman, Guilherme Safioti & Richard W. Costello. (2018) Digital technologies and adherence in respiratory diseases: the road ahead. European Respiratory Journal 52:5, pages 1801147.
Crossref
Crossref
Merja KirjavainenLeena MattilaMikko VahteristoJani KorhonenSatu Lähelmä. (2018) Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects. Journal of Aerosol Medicine and Pulmonary Drug Delivery 31:5, pages 290-297.
Crossref
Crossref
Suhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K. Manu, Alian A. Alrasheedy, Brian Godman & Donald E. Morisky. (2018) Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study. Research in Social and Administrative Pharmacy 14:10, pages 909-914.
Crossref
Crossref
Karine Wabø Ruud, Stine Wang Rønningen, Per Kristian Faksvåg, Hilde Ariansen & Ragnar Hovland. (2018) Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies. Patient Education and Counseling 101:10, pages 1828-1837.
Crossref
Crossref
Martin Wallin, Tatsuaki Tagami, Lan Chen, Mingshi Yang & Hak-Kim Chan. (2018) Pulmonary drug delivery to older people. Advanced Drug Delivery Reviews 135, pages 50-61.
Crossref
Crossref
Gary T. Ferguson, Alberto Papi, Antonio Anzueto, Edward M. Kerwin, Christy Cappelletti, Elizabeth A. Duncan, Jack Nyberg & Paul Dorinsky. (2018) Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study. European Respiratory Journal 52:3, pages 1801334.
Crossref
Crossref
Jane Scullion. (2018) The Nurse Practitioners’ Perspective on Inhaler Education in Asthma and Chronic Obstructive Pulmonary Disease. Canadian Respiratory Journal 2018, pages 1-9.
Crossref
Crossref
Hye Jung Park, Min Kwang Byun, Jae-Woo Kwon, Woo Kyung Kim, Dong-Ho Nahm, Myung-Goo Lee, Sang-Pyo Lee, Sook Young Lee, Ji-Hyun Lee, Yi Yeong Jeong, You Sook Cho, Jeong-Hee Choi & Byoung Whui Choi. (2018) Video education versus face-to-face education on inhaler technique for patients with well-controlled or partly-controlled asthma: A phase IV, open-label, non-inferiority, multicenter, randomized, controlled trial. PLOS ONE 13:8, pages e0197358.
Crossref
Crossref
Katarzyna Luczak-Wozniak, Marta Dabrowska, Izabela Domagala, Marta Miszczuk, Wojciech Lubanski, Andrzej Leszczynski & Rafal Krenke. (2018) Mishandling of pMDI and DPI inhalers in asthma and COPD – Repetitive and non-repetitive errors. Pulmonary Pharmacology & Therapeutics 51, pages 65-72.
Crossref
Crossref
Yahiya Y. Syed & Katherine A. Lyseng-Williamson. (2018) Fluticasone furoate/umeclidinium/vilanterol dry-powder inhaler in COPD: a profile of its use in the EU. Drugs & Therapy Perspectives 34:6, pages 241-247.
Crossref
Crossref
Richard Dekhuijzen, Federico Lavorini, Omar S. Usmani & Job F.M. van Boven. (2018) Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?. The Journal of Allergy and Clinical Immunology: In Practice 6:3, pages 785-793.
Crossref
Crossref
R. Andrew McIvor, Hollie M. Devlin & Alan Kaplan. (2018) Optimizing the Delivery of Inhaled Medication for Respiratory Patients: The Role of Valved Holding Chambers. Canadian Respiratory Journal 2018, pages 1-8.
Crossref
Crossref
Maria Montes de Oca, Ana Menezes, Fernando C. Wehrmeister, Maria Victorina Lopez Varela, Alejandro Casas, Luis Ugalde, Alejandra Ramirez-Venegas, Laura Mendoza, Ana López, Filip Surmont & Marc Miravitlles. (2017) Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study. PLOS ONE 12:11, pages e0186777.
Crossref
Crossref
Ian A Yang, Juliet L Brown, Johnson George, Sue Jenkins, Christine F McDonald, Vanessa M McDonald, Kirsten Phillips, Brian J Smith, Nicholas A Zwar & Eli Dabscheck. (2017) COPD‐X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update. Medical Journal of Australia 207:10, pages 436-442.
Crossref
Crossref
Job F.M. van Boven, Federico Lavorini, P.N. Richard Dekhuijzen, Francesco Blasi, David B. Price & Giovanni Viegi. (2017) Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy. European Respiratory Journal 49:5, pages 1700076.
Crossref
Crossref